Superworth

Adma Biologics market cap ADMA

Share price times shares outstanding: what the whole company sells for, since 2013.

Today, Nov 2, 2026
$2.5B
Highest close in our data
$5.6B
May 2025

Adma Biologics is worth $2.5B at the close on Nov 2, 2026, at $11.06 a share.

That is down 28% over the last year and up 1272% over five years.

Its highest close in our data was $5.6B in May 2025.

Market cap over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHighChange
2026 so far$2.5B$1.8B$4.3B−46%
2025$4.6B$3.4B$5.6B+11%
2024$4.1B$994.3M$5.3B+304%
2023$1B$608M$1B+34%
2022$763.5M$260.4M$763.5M+177%
2021$276.1M$146M$325.1M+50%
2020$184.4M$171.8M$308.3M−21%
2019$234.3M$128.4M$315.6M+127%
2018$103.4M$83.3M$296.2M+25%
2017$82.8M$37.9M$89.2M+25%
2016$66M$44.5M$101.2M−24%
2015$86.5M$72M$106.4M−16%
2014$103.1M$68.3M$115.7M+63%
2013$63.2M$47.8M$78.4Mn/a

Against its peers

Companies in Biotechnology nearest Adma Biologics' size, closest first, today.

CompanyMarket cap
ADMAAdma Biologics$2.5B
VCELVericel$2.1B
MGTXMeiraGTx$895.1M
KRYSKrystal Biotech$8.8B
RGENRepligen$9.8B
TECHBIO-TECHNE$11.4B
HALOHalozyme Therapeutics$14.6B
NBIXNeurocrine Biosciences$14.8B
EXELExelixis$17.4B
ALNYAlnylam Pharmaceuticals$21.2B
INCYIncyte$24.3B
Peer median$13B

What the market cap tells you

Share price times shares outstanding: what the whole company sells for today.

Size, not quality. Large caps move slower and are covered more. That is all it tells you.

More on Adma Biologics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.